tiprankstipranks
Pharming Group Strengthens Pipeline with Abliva Acquisition
PremiumCompany AnnouncementsPharming Group Strengthens Pipeline with Abliva Acquisition
2M ago
Pharming announces public cash offer to shareholders of Abliva AB
Premium
The Fly
Pharming announces public cash offer to shareholders of Abliva AB
2M ago
Pharming Group’s Pediatric Trial Yields Positive Results
Premium
Company Announcements
Pharming Group’s Pediatric Trial Yields Positive Results
2M ago
Pharming Group N.V. (PHGUF) Q3 Earnings Cheat Sheet
PremiumPre-EarningsPharming Group N.V. (PHGUF) Q3 Earnings Cheat Sheet
3M ago
Pharming Group Announces Q3 2024 Financial Results
Premium
Company Announcements
Pharming Group Announces Q3 2024 Financial Results
4M ago
Pharming Group Begins Leniolisib Phase II Trial
Premium
Company Announcements
Pharming Group Begins Leniolisib Phase II Trial
4M ago
Pharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
PremiumThe FlyPharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
11M ago
PHGUF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PHGUF Earnings this Week: How Will it Perform?
11M ago
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
Premium
The Fly
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100